Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 4, 1999

View Archived Issues

Company Profile: Metabolic Pharmaceuticals

Anticancer immunotoxin available for licensing from NIH

Antimalarial alkaloid compounds available for licensing from NIH

New anti-HIV compound progresses in clinical studies at BMS

Triangle initiates phase II/III testing of FTC in HIV and HBV infections

New treatment for AIDS-related pain progresses to clinical testing

12-HETE inhibitor suppresses coronary thrombosis in dog model

Novel compounds synthesized at SmithKline Beecham act at several 5-HT receptor subtypes

New COX-2 inhibitor series patented by Searle

Thrombin inhibitors in development at Lilly

Lilly's new 5-HT1D agonists claimed for CNS and bladder disorders

Warner-Lambert claims new kappa-opioid agonists and their use

Expanded use of Photofrin approved by FDA

Prometrium cleared for U.S. marketing for HRT

Telomerase expression extends lifespan of normal human cells without oncogenic transformation

New research agreement to advance development of Medical Discoveries' novel AIDS drug

Important end-of-year approval by FDA: Celebrex for arthritis

Oligo- and polyribonucleotides with anti-HIV and anti-HCMV activity

Selective inhibitor of neuronal dopamine transporter developed by U.S. university team

Physician recommendations for Viagra use issued

Antiulcer effects and mechanism of action of AU-006 explored

MCC-555 improves metabolic status, insulin sensitivity in diabetic and obese rat models

Potent antimalarial activity demonstrated for diterpenoid produced by Okinawan sponge

ACE inhibitor trandolapril improves peripheral neuropathy in normotensive diabetic patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...